Skip to content

Cases Peaked Before Mass Vaccination Took Hold

Day 1 · 0:50:28 · Ron Johnson · Shawn Buckley

  • 📉 A US cases-versus-vaccination chart shows new infections already falling hard by early 2021.
  • 💉 Johnson argues a truly sterilizing vaccine should have produced a long tail once coverage hit 60–70%.
  • 🦠 He credits virologist Geert Vanden Bossche’s warning that mid-pandemic mass vaccination would drive variants such as Delta.

Chart-driven discussion of epidemic curves and vaccine timing.

← Formal Testimony: Early Data Versus Draconian Fear | The ‘COVID Cartel’ and Sabotaged Early Treatment →

Transcript

Ron Johnson · 0:50:28

So let me interrupt myself right now because I think this is— I want to put up a chart and I got the clicker. I haven't quite understood why this chart— well, I actually do understand it, but this chart or similar charts should have gotten a lot more attention. What this chart shows are the blue bars bars. Those are new cases per day. The, the orange line is a percent of the U.S. population vaccinated. Now, now what's important about this chart? First of all, recognize the number of new cases pretty well peaked by January of 2021. Again, this is U.S. government data. I'm not making this up. This is real hard Canada. And you can see how precipitously the new cases were falling. The pandemic was fading by the time you had any kind of significant increase in vaccination.

Ron Johnson · 0:51:28

The, you know, already by March, it's, it's again, it's, it's way down and vaccination rates are only 12%. Now, had the vaccine actually worked, I mean, the way I would have thought the vaccine actually working is once 60, 70% of Americans were vaccinated, you'd see just a long tail and the pandemic would be over. That's not what happened. You know, very early in the— during the administration of the vaccines, I, I became aware of a Belgian doctor, Dr. Geert Vanden Bosch. He's not only a doctor in veterinary medicine, but he's a PhD in immunology. In, in, in virology. He worked in all kinds of biotech businesses— Glasgow SmithKline, Novartis. He, he also worked for the Bill and Linda Gates Foundation and for Gavi. Again, this is a respected virologist. He, he knows something about vaccines and immunology.

Ron Johnson · 0:52:29

He was out saying that mass vaccination in the midst of a global pandemic was probably the worst possible thing you could do because the virus, which, which, uh, evolves rapidly, would evolve to evade those vaccines. And you'd literally, you would literally drive variants. That second peak you see in this chart, that's, that's Delta, which according to doctors that I knew that was out, they were out there treating, actually treating COVID patients, uh, found it to be a far more deadlier version, variant, than the Alpha. This variant was followed by Omicron, which was less deadly but more transmissible. So again, that, that's, that's what we were actually dealing with. But public health officials, they weren't acknowledging this. They want to make sure they got that experimental gene therapy in every arm.

Shawn Buckley · 0:53:31

Let me continue.